Hiding in Plain Sight: A Consideration of NF1-Associated Hypovitaminosis D and its Treatment

作者: Vincent M. Riccardi

DOI: 10.4172/2157-7412.1000223

关键词: PathologyHypovitaminosisGenetic disorderCognitive psychologyNeurofibromatosisMedicine

摘要: This article deals with the autosomal dominant human genetic disorder, Neurofibromatosis Type 1 (NF1), and has three main foci. The first is general principle that substantial advances in understanding pathogenesis of a disorder can derive from timely reconsideration material previously overlooked or otherwise not given its due. There are times when key to supposed “mystery” hiding plain sight. second focus specific consideration selected elements an apparent vitamin D deficiency NF1. And third this reconsiders mast cell NF1 pathogenesis, including potential being “mastocytosis” sorts, prospect additional grounds for treatment blockers, example, ketotifen.

参考文章(30)
S. M. Huson, R. Rawer, Stephen A Roberts, C. Chaloner, J. Eelloo, C. W. Hockett, J. L. Berry, M. Zulf Mughal, Vitamin D status and muscle function in children with neurofibromatosis type 1 (NF1). Journal of Musculoskeletal & Neuronal Interactions. ,vol. 13, pp. 111- 119 ,(2013)
Masutaka Furue, Hiromaro Kiryu, Kazunori Urabe, Satoko Shibata, Tetsuya Koga, Juichiro Nakayama, Shinjiro Matsuo, Vitamin D3 analogues improve café au lait spots in patients with von Recklinghausen’s disease : experimental and clinical studies European Journal of Dermatology. ,vol. 9, pp. 202- 206 ,(1999)
Eetu Heervä, Laura Huilaja, Pekka Leinonen, Sirkku Peltonen, Juha Peltonen, Follow-up of six patients with neurofibromatosis 1-related osteoporosis treated with alendronate for 23 months. Calcified Tissue International. ,vol. 94, pp. 608- 612 ,(2014) , 10.1007/S00223-013-9835-2
Claudia Schnabel, Stefan Dahm, Thomas Streichert, Wulf Thierfelder, Lan Kluwe, Victor F. Mautner, Differences of 25-hydroxyvitamin D3 concentrations in children and adults with neurofibromatosis type 1. Clinical Biochemistry. ,vol. 47, pp. 560- 563 ,(2014) , 10.1016/J.CLINBIOCHEM.2014.02.020
Greg P. Blaney, Paul J. Albert, Amy D. Proal, Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Annals of the New York Academy of Sciences. ,vol. 1173, pp. 384- 390 ,(2009) , 10.1111/J.1749-6632.2009.04875.X
Sineli R. Silveira, Walter A. Hadler, A histochemical study on the vitamin D synthesis into the epidermis. Acta Histochemica. ,vol. 76, pp. 225- 234 ,(1985) , 10.1016/S0065-1281(85)80064-7
J. J. Ryan, K. A. Klein, T. J. Neuberger, J. A. Leftwich, E. H. Westin, S. Kauma, J. A. Fletcher, G. H. DeVries, T. F. Huff, Role for the stem cell factor/KIT complex in schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis Journal of Neuroscience Research. ,vol. 37, pp. 415- 432 ,(1994) , 10.1002/JNR.490370314
Vincent M. Riccardi, Mast-Cell Stabilization to Decrease Neurofibroma Growth Archives of Dermatology. ,vol. 123, pp. 1011- 1016 ,(1987) , 10.1001/ARCHDERM.1987.01660320053011
Shun'ichi Sawada, Scott Florell, Smita M. Purandare, Mayumi Ota, Karen Stephens, David Viskochil, Identification of NF1 mutations in both alleles of a dermal neurofibroma Nature Genetics. ,vol. 14, pp. 110- 112 ,(1996) , 10.1038/NG0996-110
Tommi Kuorilehto, Marja Nissinen, Jussi Koivunen, M Douglas Benson, Juha Peltonen, NF1 Tumor Suppressor Protein and mRNA in Skeletal Tissues of Developing and Adult Normal Mouse and NF1‐Deficient Embryos Journal of Bone and Mineral Research. ,vol. 19, pp. 983- 989 ,(2004) , 10.1359/JBMR.040130